Key Takeaways
- Eli Lilly's (LLY) investigational oral GLP-1 agonist, Orforglipron, has delivered positive results across multiple Phase 3 trials, showing significant weight loss and A1C reductions, completing the necessary clinical data for global regulatory submissions.
- AT&T (T) announced a substantial $23 billion all-cash acquisition of spectrum licenses from EchoStar (SATS), reinforcing its 5G and home internet capabilities while reaffirming its 2025 financial guidance and a $20 billion share repurchase plan for 2025-2027.
- PetroChina (PTR) plans to acquire gas storage companies in a deal valued at 40 billion Yuan, signaling strategic investments in energy infrastructure.
- Bitwise has filed for a spot Chainlink ETF, reflecting the increasing institutional interest in cryptocurrency-backed exchange-traded funds.
Eli Lilly's Orforglipron Shows Strong Phase 3 Results
Eli Lilly and Company (LLY) has reported compelling positive topline results from its Phase 3 clinical trial program for orforglipron, an investigational once-daily oral glucagon-like peptide-1 (GLP-1) receptor agonist, for both obesity and type 2 diabetes. The drug met all primary and key secondary endpoints across multiple studies, positioning it for global regulatory submissions.
In the ATTAIN-1 trial, evaluating adults with obesity or overweight without diabetes, the highest dose of orforglipron (36 mg) led to an average weight reduction of 12.4% (27.3 lbs) over 72 weeks, compared to 0.9% (2.2 lbs) with placebo. Furthermore, 59.6% of participants on the highest dose achieved at least 10% weight loss, with 39.6% losing 15% or more. The trial also indicated reductions in cardiovascular risk markers such as non-HDL cholesterol, triglycerides, and systolic blood pressure.
For patients with obesity or overweight and type 2 diabetes, the ATTAIN-2 trial demonstrated that orforglipron 36 mg reduced weight by an average of 10.5% (22.9 lbs), alongside a significant 1.8% reduction in A1C. In the ACHIEVE-1 trial focusing on type 2 diabetes, orforglipron lowered A1C by an average of 1.3% to 1.6% from a baseline of 8.0%, with over 65% of patients on the highest dose achieving an A1C of ≤6.5%. This trial also showed an average weight loss of 7.9% (16.0 lbs) at the highest dose.
Eli Lilly plans to submit orforglipron for regulatory review for obesity by the end of 2025, with a submission for type 2 diabetes anticipated in 2026. Despite the strong clinical data, Lilly's stock saw a 14% drop following the ATTAIN-1 results, as some market expectations for weight loss were higher, comparing it to injectable competitors like Novo Nordisk's Wegovy and Lilly's own Zepbound, which have shown greater weight reduction percentages.
AT&T's Strategic $23 Billion Spectrum Acquisition
Telecommunications giant AT&T (T) has announced a significant agreement to acquire wireless spectrum licenses from EchoStar (SATS) for approximately $23 billion in an all-cash transaction. This deal includes roughly 30 MHz of nationwide 3.45 GHz mid-band spectrum and 20 MHz of 600 MHz low-band spectrum, totaling about 50 MHz across over 400 markets in the U.S. The acquisition is expected to bolster AT&T's 5G wireless and home internet (AT&T Internet Air) capabilities, enabling rapid deployment of the newly acquired mid-band licenses.
The transaction is anticipated to close in mid-2026, pending regulatory approvals. AT&T intends to finance the purchase using existing cash reserves and incremental borrowings. The company has reaffirmed its full-year 2025 financial guidance and its plans for $20 billion in share repurchases between 2025 and 2027. While the net debt-to-adjusted EBITDA ratio is projected to temporarily increase to 3x, AT&T aims to return to its long-term target of 2.5x within approximately three years.
In a related development, AT&T and EchoStar have enhanced their wholesale network services agreement, which will allow EchoStar to operate as a hybrid mobile network operator under the Boost Mobile brand, leveraging AT&T's extensive network. This strategic partnership is also seen as a step by EchoStar to address inquiries from the Federal Communications Commission (FCC) regarding spectrum utilization. Citi (C) has assigned a positive 90-day short-term view to AT&T, anticipating improved market confidence in the stock.
Other Market Highlights
In the energy sector, PetroChina (PTR) has announced plans for a significant investment, looking to acquire gas storage companies for 40 billion Yuan. This move underscores the company's strategy to enhance its energy infrastructure and capabilities.
The digital asset space continues to evolve with Bitwise filing for a spot Chainlink ETF. This development signals growing mainstream acceptance and investment product diversification within the cryptocurrency market.
Globally, the European Union has addressed concerns regarding its digital regulations, stating that claims of censorship are "unfounded." Meanwhile, an opinion piece highlighted the robust growth in global jet fuel demand, driven by the increasing air travel aspirations of wealthy Asian urbanites, suggesting a bright spot for oil demand.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.